Global Human Gene Therapy Market Growth 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Gene Therapy Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Human Gene Therapy by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Human Gene Therapy by Country/Region, 2017, 2022 & 2028
2.2 Human Gene Therapy Segment by Type
2.2.1 Non-viral Vectors
2.2.2 Viral Vectors
2.3 Human Gene Therapy Sales by Type
2.3.1 Global Human Gene Therapy Sales Market Share by Type (2017-2022)
2.3.2 Global Human Gene Therapy Revenue and Market Share by Type (2017-2022)
2.3.3 Global Human Gene Therapy Sale Price by Type (2017-2022)
2.4 Human Gene Therapy Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 DMD (Duchenne Muscular Dystrophy)
2.4.4 Hepatological Diseases
2.4.5 Others
2.5 Human Gene Therapy Sales by Application
2.5.1 Global Human Gene Therapy Sale Market Share by Application (2017-2022)
2.5.2 Global Human Gene Therapy Revenue and Market Share by Application (2017-2022)
2.5.3 Global Human Gene Therapy Sale Price by Application (2017-2022)
3 Global Human Gene Therapy by Company
3.1 Global Human Gene Therapy Breakdown Data by Company
3.1.1 Global Human Gene Therapy Annual Sales by Company (2020-2022)
3.1.2 Global Human Gene Therapy Sales Market Share by Company (2020-2022)
3.2 Global Human Gene Therapy Annual Revenue by Company (2020-2022)
3.2.1 Global Human Gene Therapy Revenue by Company (2020-2022)
3.2.2 Global Human Gene Therapy Revenue Market Share by Company (2020-2022)
3.3 Global Human Gene Therapy Sale Price by Company
3.4 Key Manufacturers Human Gene Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Gene Therapy Product Location Distribution
3.4.2 Players Human Gene Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Gene Therapy by Geographic Region
4.1 World Historic Human Gene Therapy Market Size by Geographic Region (2017-2022)
4.1.1 Global Human Gene Therapy Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Human Gene Therapy Annual Revenue by Geographic Region
4.2 World Historic Human Gene Therapy Market Size by Country/Region (2017-2022)
4.2.1 Global Human Gene Therapy Annual Sales by Country/Region (2017-2022)
4.2.2 Global Human Gene Therapy Annual Revenue by Country/Region
4.3 Americas Human Gene Therapy Sales Growth
4.4 APAC Human Gene Therapy Sales Growth
4.5 Europe Human Gene Therapy Sales Growth
4.6 Middle East & Africa Human Gene Therapy Sales Growth
5 Americas
5.1 Americas Human Gene Therapy Sales by Country
5.1.1 Americas Human Gene Therapy Sales by Country (2017-2022)
5.1.2 Americas Human Gene Therapy Revenue by Country (2017-2022)
5.2 Americas Human Gene Therapy Sales by Type
5.3 Americas Human Gene Therapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Gene Therapy Sales by Region
6.1.1 APAC Human Gene Therapy Sales by Region (2017-2022)
6.1.2 APAC Human Gene Therapy Revenue by Region (2017-2022)
6.2 APAC Human Gene Therapy Sales by Type
6.3 APAC Human Gene Therapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Gene Therapy by Country
7.1.1 Europe Human Gene Therapy Sales by Country (2017-2022)
7.1.2 Europe Human Gene Therapy Revenue by Country (2017-2022)
7.2 Europe Human Gene Therapy Sales by Type
7.3 Europe Human Gene Therapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Gene Therapy by Country
8.1.1 Middle East & Africa Human Gene Therapy Sales by Country (2017-2022)
8.1.2 Middle East & Africa Human Gene Therapy Revenue by Country (2017-2022)
8.2 Middle East & Africa Human Gene Therapy Sales by Type
8.3 Middle East & Africa Human Gene Therapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Gene Therapy
10.3 Manufacturing Process Analysis of Human Gene Therapy
10.4 Industry Chain Structure of Human Gene Therapy
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Gene Therapy Distributors
11.3 Human Gene Therapy Customer
12 World Forecast Review for Human Gene Therapy by Geographic Region
12.1 Global Human Gene Therapy Market Size Forecast by Region
12.1.1 Global Human Gene Therapy Forecast by Region (2023-2028)
12.1.2 Global Human Gene Therapy Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Gene Therapy Forecast by Type
12.7 Global Human Gene Therapy Forecast by Application
13 Key Players Analysis
13.1 Biogen
13.1.1 Biogen Company Information
13.1.2 Biogen Human Gene Therapy Product Offered
13.1.3 Biogen Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Biogen Main Business Overview
13.1.5 Biogen Latest Developments
13.2 Sarepta Therapeutics
13.2.1 Sarepta Therapeutics Company Information
13.2.2 Sarepta Therapeutics Human Gene Therapy Product Offered
13.2.3 Sarepta Therapeutics Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sarepta Therapeutics Main Business Overview
13.2.5 Sarepta Therapeutics Latest Developments
13.3 Gilead Sciences
13.3.1 Gilead Sciences Company Information
13.3.2 Gilead Sciences Human Gene Therapy Product Offered
13.3.3 Gilead Sciences Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Gilead Sciences Main Business Overview
13.3.5 Gilead Sciences Latest Developments
13.4 Amgen
13.4.1 Amgen Company Information
13.4.2 Amgen Human Gene Therapy Product Offered
13.4.3 Amgen Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Amgen Main Business Overview
13.4.5 Amgen Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Human Gene Therapy Product Offered
13.5.3 Novartis Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Orchard Therapeutics
13.6.1 Orchard Therapeutics Company Information
13.6.2 Orchard Therapeutics Human Gene Therapy Product Offered
13.6.3 Orchard Therapeutics Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Orchard Therapeutics Main Business Overview
13.6.5 Orchard Therapeutics Latest Developments
13.7 Spark Therapeutics
13.7.1 Spark Therapeutics Company Information
13.7.2 Spark Therapeutics Human Gene Therapy Product Offered
13.7.3 Spark Therapeutics Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Spark Therapeutics Main Business Overview
13.7.5 Spark Therapeutics Latest Developments
13.8 Agc Biologics
13.8.1 Agc Biologics Company Information
13.8.2 Agc Biologics Human Gene Therapy Product Offered
13.8.3 Agc Biologics Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Agc Biologics Main Business Overview
13.8.5 Agc Biologics Latest Developments
13.9 Anges
13.9.1 Anges Company Information
13.9.2 Anges Human Gene Therapy Product Offered
13.9.3 Anges Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Anges Main Business Overview
13.9.5 Anges Latest Developments
13.10 Bluebird Bio
13.10.1 Bluebird Bio Company Information
13.10.2 Bluebird Bio Human Gene Therapy Product Offered
13.10.3 Bluebird Bio Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Bluebird Bio Main Business Overview
13.10.5 Bluebird Bio Latest Developments
13.11 Jazz Pharmaceuticals
13.11.1 Jazz Pharmaceuticals Company Information
13.11.2 Jazz Pharmaceuticals Human Gene Therapy Product Offered
13.11.3 Jazz Pharmaceuticals Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Jazz Pharmaceuticals Main Business Overview
13.11.5 Jazz Pharmaceuticals Latest Developments
13.12 Dynavax Technologies
13.12.1 Dynavax Technologies Company Information
13.12.2 Dynavax Technologies Human Gene Therapy Product Offered
13.12.3 Dynavax Technologies Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Dynavax Technologies Main Business Overview
13.12.5 Dynavax Technologies Latest Developments
13.13 Human Stem Cells Institute
13.13.1 Human Stem Cells Institute Company Information
13.13.2 Human Stem Cells Institute Human Gene Therapy Product Offered
13.13.3 Human Stem Cells Institute Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Human Stem Cells Institute Main Business Overview
13.13.5 Human Stem Cells Institute Latest Developments
13.14 Sibiono Genetech
13.14.1 Sibiono Genetech Company Information
13.14.2 Sibiono Genetech Human Gene Therapy Product Offered
13.14.3 Sibiono Genetech Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Sibiono Genetech Main Business Overview
13.14.5 Sibiono Genetech Latest Developments
13.15 Shanghai Sunway Biotech
13.15.1 Shanghai Sunway Biotech Company Information
13.15.2 Shanghai Sunway Biotech Human Gene Therapy Product Offered
13.15.3 Shanghai Sunway Biotech Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Shanghai Sunway Biotech Main Business Overview
13.15.5 Shanghai Sunway Biotech Latest Developments
13.16 Uniqure N.V.
13.16.1 Uniqure N.V. Company Information
13.16.2 Uniqure N.V. Human Gene Therapy Product Offered
13.16.3 Uniqure N.V. Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Uniqure N.V. Main Business Overview
13.16.5 Uniqure N.V. Latest Developments
13.17 Gensight Biologics S.A.
13.17.1 Gensight Biologics S.A. Company Information
13.17.2 Gensight Biologics S.A. Human Gene Therapy Product Offered
13.17.3 Gensight Biologics S.A. Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Gensight Biologics S.A. Main Business Overview
13.17.5 Gensight Biologics S.A. Latest Developments
13.18 Celgene Corporation
13.18.1 Celgene Corporation Company Information
13.18.2 Celgene Corporation Human Gene Therapy Product Offered
13.18.3 Celgene Corporation Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Celgene Corporation Main Business Overview
13.18.5 Celgene Corporation Latest Developments
13.19 Cellectis
13.19.1 Cellectis Company Information
13.19.2 Cellectis Human Gene Therapy Product Offered
13.19.3 Cellectis Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Cellectis Main Business Overview
13.19.5 Cellectis Latest Developments
13.20 Sangamo Therapeutics
13.20.1 Sangamo Therapeutics Company Information
13.20.2 Sangamo Therapeutics Human Gene Therapy Product Offered
13.20.3 Sangamo Therapeutics Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Sangamo Therapeutics Main Business Overview
13.20.5 Sangamo Therapeutics Latest Developments
13.21 Mustang Bio
13.21.1 Mustang Bio Company Information
13.21.2 Mustang Bio Human Gene Therapy Product Offered
13.21.3 Mustang Bio Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Mustang Bio Main Business Overview
13.21.5 Mustang Bio Latest Developments
13.22 AGTC
13.22.1 AGTC Company Information
13.22.2 AGTC Human Gene Therapy Product Offered
13.22.3 AGTC Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 AGTC Main Business Overview
13.22.5 AGTC Latest Developments
13.23 Poseida Therapeutics
13.23.1 Poseida Therapeutics Company Information
13.23.2 Poseida Therapeutics Human Gene Therapy Product Offered
13.23.3 Poseida Therapeutics Human Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Poseida Therapeutics Main Business Overview
13.23.5 Poseida Therapeutics Latest Developments
14 Research Findings and Conclusion


List of Tables
Table 1. Human Gene Therapy Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Human Gene Therapy Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Non-viral Vectors
Table 4. Major Players of Viral Vectors
Table 5. Global Human Gene Therapy Sales by Type (2017-2022) & (K Units)
Table 6. Global Human Gene Therapy Sales Market Share by Type (2017-2022)
Table 7. Global Human Gene Therapy Revenue by Type (2017-2022) & ($ million)
Table 8. Global Human Gene Therapy Revenue Market Share by Type (2017-2022)
Table 9. Global Human Gene Therapy Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Human Gene Therapy Sales by Application (2017-2022) & (K Units)
Table 11. Global Human Gene Therapy Sales Market Share by Application (2017-2022)
Table 12. Global Human Gene Therapy Revenue by Application (2017-2022)
Table 13. Global Human Gene Therapy Revenue Market Share by Application (2017-2022)
Table 14. Global Human Gene Therapy Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Human Gene Therapy Sales by Company (2020-2022) & (K Units)
Table 16. Global Human Gene Therapy Sales Market Share by Company (2020-2022)
Table 17. Global Human Gene Therapy Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Human Gene Therapy Revenue Market Share by Company (2020-2022)
Table 19. Global Human Gene Therapy Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Human Gene Therapy Producing Area Distribution and Sales Area
Table 21. Players Human Gene Therapy Products Offered
Table 22. Human Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Human Gene Therapy Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Human Gene Therapy Sales Market Share Geographic Region (2017-2022)
Table 27. Global Human Gene Therapy Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Human Gene Therapy Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Human Gene Therapy Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Human Gene Therapy Sales Market Share by Country/Region (2017-2022)
Table 31. Global Human Gene Therapy Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Human Gene Therapy Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Human Gene Therapy Sales by Country (2017-2022) & (K Units)
Table 34. Americas Human Gene Therapy Sales Market Share by Country (2017-2022)
Table 35. Americas Human Gene Therapy Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Human Gene Therapy Revenue Market Share by Country (2017-2022)
Table 37. Americas Human Gene Therapy Sales by Type (2017-2022) & (K Units)
Table 38. Americas Human Gene Therapy Sales Market Share by Type (2017-2022)
Table 39. Americas Human Gene Therapy Sales by Application (2017-2022) & (K Units)
Table 40. Americas Human Gene Therapy Sales Market Share by Application (2017-2022)
Table 41. APAC Human Gene Therapy Sales by Region (2017-2022) & (K Units)
Table 42. APAC Human Gene Therapy Sales Market Share by Region (2017-2022)
Table 43. APAC Human Gene Therapy Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Human Gene Therapy Revenue Market Share by Region (2017-2022)
Table 45. APAC Human Gene Therapy Sales by Type (2017-2022) & (K Units)
Table 46. APAC Human Gene Therapy Sales Market Share by Type (2017-2022)
Table 47. APAC Human Gene Therapy Sales by Application (2017-2022) & (K Units)
Table 48. APAC Human Gene Therapy Sales Market Share by Application (2017-2022)
Table 49. Europe Human Gene Therapy Sales by Country (2017-2022) & (K Units)
Table 50. Europe Human Gene Therapy Sales Market Share by Country (2017-2022)
Table 51. Europe Human Gene Therapy Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Human Gene Therapy Revenue Market Share by Country (2017-2022)
Table 53. Europe Human Gene Therapy Sales by Type (2017-2022) & (K Units)
Table 54. Europe Human Gene Therapy Sales Market Share by Type (2017-2022)
Table 55. Europe Human Gene Therapy Sales by Application (2017-2022) & (K Units)
Table 56. Europe Human Gene Therapy Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Human Gene Therapy Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Human Gene Therapy Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Human Gene Therapy Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Human Gene Therapy Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Human Gene Therapy Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Human Gene Therapy Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Human Gene Therapy Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Human Gene Therapy Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Human Gene Therapy
Table 66. Key Market Challenges & Risks of Human Gene Therapy
Table 67. Key Industry Trends of Human Gene Therapy
Table 68. Human Gene Therapy Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Human Gene Therapy Distributors List
Table 71. Human Gene Therapy Customer List
Table 72. Global Human Gene Therapy Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Human Gene Therapy Sales Market Forecast by Region
Table 74. Global Human Gene Therapy Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Human Gene Therapy Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Human Gene Therapy Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Human Gene Therapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Human Gene Therapy Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Human Gene Therapy Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Human Gene Therapy Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Human Gene Therapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Human Gene Therapy Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Human Gene Therapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Human Gene Therapy Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Human Gene Therapy Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Human Gene Therapy Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Human Gene Therapy Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Human Gene Therapy Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Human Gene Therapy Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Human Gene Therapy Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Human Gene Therapy Revenue Market Share Forecast by Application (2023-2028)
Table 92. Biogen Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 93. Biogen Human Gene Therapy Product Offered
Table 94. Biogen Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Biogen Main Business
Table 96. Biogen Latest Developments
Table 97. Sarepta Therapeutics Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 98. Sarepta Therapeutics Human Gene Therapy Product Offered
Table 99. Sarepta Therapeutics Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Sarepta Therapeutics Main Business
Table 101. Sarepta Therapeutics Latest Developments
Table 102. Gilead Sciences Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 103. Gilead Sciences Human Gene Therapy Product Offered
Table 104. Gilead Sciences Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Gilead Sciences Main Business
Table 106. Gilead Sciences Latest Developments
Table 107. Amgen Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 108. Amgen Human Gene Therapy Product Offered
Table 109. Amgen Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Amgen Main Business
Table 111. Amgen Latest Developments
Table 112. Novartis Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 113. Novartis Human Gene Therapy Product Offered
Table 114. Novartis Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Novartis Main Business
Table 116. Novartis Latest Developments
Table 117. Orchard Therapeutics Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 118. Orchard Therapeutics Human Gene Therapy Product Offered
Table 119. Orchard Therapeutics Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Orchard Therapeutics Main Business
Table 121. Orchard Therapeutics Latest Developments
Table 122. Spark Therapeutics Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 123. Spark Therapeutics Human Gene Therapy Product Offered
Table 124. Spark Therapeutics Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Spark Therapeutics Main Business
Table 126. Spark Therapeutics Latest Developments
Table 127. Agc Biologics Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 128. Agc Biologics Human Gene Therapy Product Offered
Table 129. Agc Biologics Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Agc Biologics Main Business
Table 131. Agc Biologics Latest Developments
Table 132. Anges Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 133. Anges Human Gene Therapy Product Offered
Table 134. Anges Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Anges Main Business
Table 136. Anges Latest Developments
Table 137. Bluebird Bio Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 138. Bluebird Bio Human Gene Therapy Product Offered
Table 139. Bluebird Bio Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Bluebird Bio Main Business
Table 141. Bluebird Bio Latest Developments
Table 142. Jazz Pharmaceuticals Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 143. Jazz Pharmaceuticals Human Gene Therapy Product Offered
Table 144. Jazz Pharmaceuticals Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Jazz Pharmaceuticals Main Business
Table 146. Jazz Pharmaceuticals Latest Developments
Table 147. Dynavax Technologies Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 148. Dynavax Technologies Human Gene Therapy Product Offered
Table 149. Dynavax Technologies Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Dynavax Technologies Main Business
Table 151. Dynavax Technologies Latest Developments
Table 152. Human Stem Cells Institute Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 153. Human Stem Cells Institute Human Gene Therapy Product Offered
Table 154. Human Stem Cells Institute Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Human Stem Cells Institute Main Business
Table 156. Human Stem Cells Institute Latest Developments
Table 157. Sibiono Genetech Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 158. Sibiono Genetech Human Gene Therapy Product Offered
Table 159. Sibiono Genetech Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Sibiono Genetech Main Business
Table 161. Sibiono Genetech Latest Developments
Table 162. Shanghai Sunway Biotech Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 163. Shanghai Sunway Biotech Human Gene Therapy Product Offered
Table 164. Shanghai Sunway Biotech Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Shanghai Sunway Biotech Main Business
Table 166. Shanghai Sunway Biotech Latest Developments
Table 167. Uniqure N.V. Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 168. Uniqure N.V. Human Gene Therapy Product Offered
Table 169. Uniqure N.V. Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Uniqure N.V. Main Business
Table 171. Uniqure N.V. Latest Developments
Table 172. Gensight Biologics S.A. Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 173. Gensight Biologics S.A. Human Gene Therapy Product Offered
Table 174. Gensight Biologics S.A. Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Gensight Biologics S.A. Main Business
Table 176. Gensight Biologics S.A. Latest Developments
Table 177. Celgene Corporation Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 178. Celgene Corporation Human Gene Therapy Product Offered
Table 179. Celgene Corporation Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 180. Celgene Corporation Main Business
Table 181. Celgene Corporation Latest Developments
Table 182. Cellectis Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 183. Cellectis Human Gene Therapy Product Offered
Table 184. Cellectis Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 185. Cellectis Main Business
Table 186. Cellectis Latest Developments
Table 187. Sangamo Therapeutics Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 188. Sangamo Therapeutics Human Gene Therapy Product Offered
Table 189. Sangamo Therapeutics Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 190. Sangamo Therapeutics Main Business
Table 191. Sangamo Therapeutics Latest Developments
Table 192. Mustang Bio Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 193. Mustang Bio Human Gene Therapy Product Offered
Table 194. Mustang Bio Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 195. Mustang Bio Main Business
Table 196. Mustang Bio Latest Developments
Table 197. AGTC Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 198. AGTC Human Gene Therapy Product Offered
Table 199. AGTC Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 200. AGTC Main Business
Table 201. AGTC Latest Developments
Table 202. Poseida Therapeutics Basic Information, Human Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 203. Poseida Therapeutics Human Gene Therapy Product Offered
Table 204. Poseida Therapeutics Human Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 205. Poseida Therapeutics Main Business
Table 206. Poseida Therapeutics Latest Developments
List of Figures
Figure 1. Picture of Human Gene Therapy
Figure 2. Human Gene Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Gene Therapy Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Human Gene Therapy Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Human Gene Therapy Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Non-viral Vectors
Figure 10. Product Picture of Viral Vectors
Figure 11. Global Human Gene Therapy Sales Market Share by Type in 2021
Figure 12. Global Human Gene Therapy Revenue Market Share by Type (2017-2022)
Figure 13. Human Gene Therapy Consumed in Neurological Diseases
Figure 14. Global Human Gene Therapy Market: Neurological Diseases (2017-2022) & (K Units)
Figure 15. Human Gene Therapy Consumed in Cancer
Figure 16. Global Human Gene Therapy Market: Cancer (2017-2022) & (K Units)
Figure 17. Human Gene Therapy Consumed in DMD (Duchenne Muscular Dystrophy)
Figure 18. Global Human Gene Therapy Market: DMD (Duchenne Muscular Dystrophy) (2017-2022) & (K Units)
Figure 19. Human Gene Therapy Consumed in Hepatological Diseases
Figure 20. Global Human Gene Therapy Market: Hepatological Diseases (2017-2022) & (K Units)
Figure 21. Human Gene Therapy Consumed in Others
Figure 22. Global Human Gene Therapy Market: Others (2017-2022) & (K Units)
Figure 23. Global Human Gene Therapy Sales Market Share by Application (2017-2022)
Figure 24. Global Human Gene Therapy Revenue Market Share by Application in 2021
Figure 25. Human Gene Therapy Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Human Gene Therapy Revenue Market Share by Company in 2021
Figure 27. Global Human Gene Therapy Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Human Gene Therapy Revenue Market Share by Geographic Region in 2021
Figure 29. Global Human Gene Therapy Sales Market Share by Region (2017-2022)
Figure 30. Global Human Gene Therapy Revenue Market Share by Country/Region in 2021
Figure 31. Americas Human Gene Therapy Sales 2017-2022 (K Units)
Figure 32. Americas Human Gene Therapy Revenue 2017-2022 ($ Millions)
Figure 33. APAC Human Gene Therapy Sales 2017-2022 (K Units)
Figure 34. APAC Human Gene Therapy Revenue 2017-2022 ($ Millions)
Figure 35. Europe Human Gene Therapy Sales 2017-2022 (K Units)
Figure 36. Europe Human Gene Therapy Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Human Gene Therapy Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Human Gene Therapy Revenue 2017-2022 ($ Millions)
Figure 39. Americas Human Gene Therapy Sales Market Share by Country in 2021
Figure 40. Americas Human Gene Therapy Revenue Market Share by Country in 2021
Figure 41. United States Hum